Global Core Electronic Medicinal Product Information (ePI)
1.1.0 - trial-use International flag

Global Core Electronic Medicinal Product Information (ePI), published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/emedicinal-product-info/ and changes regularly. See the Directory of published versions

: RegulatedAuthorization - WonderDrug 500 mg

Page standards status: Informative

Raw xml | Download


<RegulatedAuthorization xmlns="http://hl7.org/fhir">
  <id value="ra-epi-type2-example-paracetamol"/>
  <meta>
    <profile
             value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi"/>
  </meta>
  <language value="en"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><p class="res-header-id"><b>Generated Narrative: RegulatedAuthorization ra-epi-type2-example-paracetamol</b></p><a name="ra-epi-type2-example-paracetamol"> </a><a name="hcra-epi-type2-example-paracetamol"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Language: en</p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-RegulatedAuthorization-uv-epi.html">RegulatedAuthorization (ePI)</a></p></div><p><b>identifier</b>: <code>http://ema.europa.eu/identifier</code>/MA-123456789</p><p><b>subject</b>: <a href="Bundle-bundle-epi-type2-example-paracetamol.html#http-//hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/mpd-epi-type2-example-paracetamol">MedicinalProductDefinition: identifier = http://ema.europa.eu/identifier#WONDERDRUG-500MG; domain = Human use; status = Active; legalStatusOfSupply = Medicinal product subject to medical prescription</a></p><p><b>type</b>: <span title="Codes:{https://spor.ema.europa.eu/rmswi 220000000061}">Marketing Authorisation</span></p><p><b>region</b>: <span title="Codes:{urn:iso:std:iso:3166 EE}">Estonia</span></p><p><b>status</b>: <span title="Codes:{http://hl7.org/fhir/publication-status active}">Active</span></p><p><b>holder</b>: <a href="Organization-org-epi-type2-example-acme.html">Organization Acme Pharma Inc.</a></p></div>
  </text>
  <identifier>
    <system value="http://ema.europa.eu/identifier"/>
    <value value="MA-123456789"/>
  </identifier>
  <subject>🔗 
    <reference
               value="http://hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/mpd-epi-type2-example-paracetamol"/>
  </subject>
  <type>
    <coding>
      <system value="https://spor.ema.europa.eu/rmswi"/>
      <code value="220000000061"/>
      <display value="Marketing Authorisation"/>
    </coding>
  </type>
  <region>
    <coding>
      <system value="urn:iso:std:iso:3166"/>
      <code value="EE"/>
      <display value="Estonia"/>
    </coding>
  </region>
  <status>
    <coding>
      <system value="http://hl7.org/fhir/publication-status"/>
      <code value="active"/>
      <display value="Active"/>
    </coding>
  </status>
  <holder>🔗 
    <reference value="Organization/org-epi-type2-example-acme"/>
  </holder>
</RegulatedAuthorization>